Patent · US Active

Choline esters

US9326970B2 · kind B2 · utility

3Cited by
49References
12Claims
0Family size

Assignee

Inventors

Key dates

Filing dateOct 28, 2014
Grant dateMay 3, 2016
Priority date
Expiry dateOct 28, 2034

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC07D343/00
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

Compounds, formulations, and methods are provided containing the choline ester of a reducing agent, especially lipoic acid or derivatives thereof. The compounds may be administered via a topical ocular route to treat or prevent oxidative damage.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.